ArticleDiscover oncology2025

Identifying and validating SMARCAL1 as a prognostic and immunotherapy predictive biomarker for NSCLC.

Zeyan Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.